Anucha Apisarnthanarak - Infectious Diseases

Author Information

Anucha Apisarnthanarak is a prominent researcher in the field of Infectious Diseases, affiliated with the Division of Infectious Diseases, Department of Medicine at Thammasat University Hospital in Pratumthani, Thailand. His work primarily focuses on infectious disease management, antimicrobial stewardship, and the epidemiology of infectious diseases within healthcare settings.

Research Contributions

Anucha Apisarnthanarak has made significant contributions to the understanding and management of infectious diseases, with a particular focus on strategies to combat COVID-19 and multidrug-resistant organisms. His recent work includes evaluating the effectiveness of COVID-19 vaccines during the delta variant dominance and exploring interventions to optimize antibiotic usage among critically ill COVID-19 patients. Additionally, his research has also addressed infection control practices in healthcare settings and specific case studies such as intestinal basidiobolomycosis in immunocompromised patients.

Aliases

Anucha Apisarnthanarak is also known by several aliases in academic publications, including A Apisarnthanarak and A. Apisarnthanarak. These variations of his name may appear in different journals and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	352
Total Citations	8359
H-index	48

Publications:

Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study

DOI: 10.1080/22221751.2022.2037398

Year: 2022

The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study

DOI: 10.1016/j.ajic.2022.01.030

Year: 2022

Factors associated with coronavirus disease 2019 (COVID-19) among Thai healthcare personnel with high-risk exposures: The important roles of double masking and physical distancing while eating

DOI: 10.1017/ice.2022.58

Year: 2022

Impact of an infectious diseases pharmacist-led intervention on antimicrobial stewardship program guideline adherence at a Thai medical center.

DOI: 10.1093/ajhp/zxac107

Year: 2022

ASHE December 2021: Reflections on our first year with an eye on the future

DOI: 10.1017/ash.2021.262

Year: 2022

Intestinal basidiobolomycosis in a patient with idiopathic CD4 lymphocytopenia.

DOI: 10.1016/j.mycmed.2022.101260

Year: 2022

Molecular characterization of methicillin-resistant Staphylococcus aureus genotype ST764-SCCmec type II in Thailand

DOI: 10.1038/s41598-022-05898-1

Year: 2022

Coronavirus disease 2019 (COVID-19) preparedness in a Thai International School: Emotional health and infection control practices

DOI: 10.1017/ice.2021.236

Year: 2021

Strategy to limit multidrug-resistant Acinetobacter baumannii transmission in a cohort coronavirus disease 2019 (COVID-19) critical care unit

DOI: 10.1017/ice.2021.289

Year: 2021

Pharmacist-Driven Antibiotic Stewardship Program in Febrile Neutropenic Patients: A Single Site Prospective Study in Thailand

DOI: 10.3390/antibiotics10040456

Year: 2021

How is Schistosomiasis Transmitted?

Is Fatigue a Long-term Issue in Infectious Diseases?

What are the Complications of Untreated Gonorrhea?

What is Vector Borne Transmission?

What is the Prognosis for Patients with ARDS?

How is Parasite DNA Detected?

Why Are Regular Health Check-Ups Important?

Why is a Malaria Vaccine Important?

What is the Treatment for Dengue Hemorrhagic Fever?

How is Colonization Detected?

Partnered Content Networks

Relevant Topics